The information provided is for convenience only. It is not investment advice or a recommendation, it does not constitute a solicitation to buy or sell securities, and it may not be relied upon in considering an investment in a Cardone fund. Past performance is no guarantee of future results. Any historical returns expected returns or probability projections may not reflect actual future performance. All securities involve risk and may result in partial or total loss. Investment in Cardone funds is available only to independently verified “accredited investors” through an offering made in accordance with Rule 506(c) under Regulation D of the Securities Act of 1933. Before investing in any Cardone fund, prospective investors should consider carefully the investment objective(s), risks, arches, and expenses. While the data we use from third parties is believed to be reliable, we cannot ensure the accuracy or completeness of the data provided. Cardone Capital does not provide legal or tax advice. Prospective investors should consult with a tax or legal adviser before making any investment decision.

How to Sell and Close in the Medical Industry – David Karli

In this Show

David C. Karli, CEO & Founder of his own biotech startup, Greyledge Technologies. He speaks about challenges he faced in the early stages of his brand development. He studied from Grant Cardone’s sales experience to work through the challenges that came up along the way. Greyledge is unique because they provide a service to physicians and hospitals.

The major problem Karli faced was getting people to sign on the dotted line. People were always excited and interested about working with Greyledge, but had a long lag time between initial interest and closing the deal. It was taking too long to launch the account and wait until the account actually generated cashflow.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

(Visited 118 times, 1 visits today)